Phone: (212) 746-5788
Fax: (212) 746-0975
March 12, 2010 3:40 pm
Multiple-agent Therapy with Metronomic Xeloda® and Nexavar® Promising for ... - Cancer Consultants
Google News - renal cell carcinoma
Multiple-agent Therapy with Metronomic Xeloda® and Nexavar® Promising for ... Cancer Consultants Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study ... |
|